Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 453, 861-862 (12 June 2008) | doi:10.1038/453861a; Published online 11 June 2008
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
- More Challenges
- Powered by:
nature jobs
Developer - Variation (Bioinformatician)
- European Bioinformatics Institute (EBI)
- Cambridge CB10 1SD United Kingdom
Chair
- McMaster University
- Hamilton, Canada
Biochemistry: Molecular cloaking devices
Thomas Kodadek1
Abstract
Protease enzymes cut other proteins into pieces, but some can be blocked by inhibitors. One such inhibitor binds to the substrate rather than the enzyme, suggesting a new tactic for drug discovery.
Most drug developers try to identify small molecules that bind to a target enzyme with high affinity and specificity. Binding usually occurs at the enzyme's active site; by nestling into this molecular pocket, the drug blocks binding of the enzyme's natural substrate.
- Thomas Kodadek is in the Departments of Internal Medicine and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9185, USA.
e-mail: Email: thomas.kodadek@utsouthwestern.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Crystal structure of human osteoclast cathepsin K complex with E-64Nature Structural Biology Correspondence (01 Feb 1997)
Substrate-targeting &ggr;-secretase modulatorsNature Letters to Editor (12 Jun 2008)
